68Ga-PSMA-11正电子发射断层扫描在多中心回顾性研究中检测前列腺切除术后残留前列腺癌
这项多中心回顾性研究纳入191例根治性前列腺切除术后持续前列腺特异性抗原(PSA)升高(≥0.1 ng/ml)的患者,评估68Ga-PSMA-11 PET/CT或PET/MRI的检出率和阳性预测值。结果显示130/191例(68%)检出前列腺癌,检出率随PSA显著升高(p<0.001),阳性预测值为91%。闭孔和骶前/直肠系膜淋巴结是持续转移的高危区域。
要点
- 68Ga-PSMA-11 PET在PSA持续≥0.1 ng/ml的患者中检出率为68%(130/191)。
- 检出率随PSA水平升高而显著增加(p<0.001)。
- 阳性预测值为91%,闭孔(42%)和骶前/直肠系膜(40%)淋巴结最常受累。
核心结论
- PSMA配体PET在高危特征且前列腺切除术后PSA持续的患者中,超过三分之二可定位前列腺癌。
- 闭孔和骶前/直肠系膜淋巴结是持续转移的高危区域。
研究设计与样本
- 多中心回顾性研究,6个参与中心共纳入191例根治性前列腺切除术后PSA持续升高(≥0.1 ng/ml)并接受68Ga-PSMA-11 PET/CT或PET/MRI的患者。
- 在33例术前额外接受PSMA配体PET的患者中,还评估了基于PET的持续率和复发率。
主要发现
- PSMA配体PET在191例PSA持续患者中检出前列腺癌130例(68%),中位PSA为1.1 ng/ml。
- 检出率随PSA显著增加(p<0.001)。
- 仅行PSMA PET/CT的173例中,61例(35%)病变局限于盆腔,57例(33%)有远处病变。
- 最常受累淋巴结区域为闭孔42%和骶前/直肠系膜40%。
- 在33例术前和术后均行PSMA配体PET的患者中,15例(45%)基线至少1个病灶(PET持续),8例(24%)出现新病灶(PET复发),10例(30%)PET阴性。
关键数值与推荐
- PSA持续定义为术后PSA≥0.1 ng/ml。
- 检出率:130/191(68%)。
- 阳性预测值:91%。
- 闭孔淋巴结受累42%,骶前/直肠系膜淋巴结受累40%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate specific antigen persistence after radical prostatectomy is associated with adverse outcomes in patients with prostate cancer. We sought to define regions at risk for residual disease as well as the accuracy of prostate specific membrane antigen ligand positron emission tomography in patients with prostate specific antigen persistence. MATERIALS AND METHODS: At 6 participating centers a total of 191 patients who underwent 68Ga-prostate specific membrane antigen-11 positron emission tomography/computerized tomography or positron emission tomography/magnetic resonance imaging for persistently elevated postoperative prostate specific antigen (0.1 ng/ml or greater) were retrospectively included in study. The detection rate and the positive predictive value were determined. In 33 patients with additional prostate specific membrane antigen ligand positron emission tomography before prostatectomy we also determined the rate of positron emission tomography based persistence and recurrence. RESULTS: Prostate specific membrane antigen ligand positron emission tomography localized prostate cancer in 130 of 191 patients (68%) with prostate specific antigen persistence at a median prostate specific antigen of 1.1 ng/ml. The detection rate significantly increased with prostate specific antigen (p <0.001). Regarding prostate specific membrane antigen positron emission tomography/computerized tomography only 61 of 173 patients (35%) had disease confined to the pelvis while 57 of 173 (33%) had distant lesions. The most frequently affected nodal regions were the obturator in 42% and the presacral/mesorectal region in 40%. In 15 of the 33 patients (45%) with prostate specific membrane antigen ligand positron emission tomography before and after surgery at least 1 lesion was detected at baseline (positron emission tomography persistence), 8 (24%) had new lesions (positron emission tomography recurrence) and 10 (30%) had negative positron emission tomography findings. The positive predictive value of prostate specific membrane antigen ligand positron emission tomography was 91%. Systemic therapy initiation was significantly associated with distant lesions on prostate specific membrane antigen ligand positron emission tomography. CONCLUSIONS: Prostate specific membrane antigen ligand positron emission tomography localized prostate cancer in more than two-thirds of patients with high risk features and prostate specific antigen persistence after prostatectomy. Obturator and presacral/mesorectal nodes are at high risk for persistent metastasis.
引用
- Farolfi A, Gafita A, Calais J, et al. 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study. J Urol. 2019. PMID: 31233369. doi:10.1097/JU.0000000000000417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。